Jugami Biology

Biology · Lesson 7

Microbiology and the Immune System

Most microbes are harmless and many are useful. This lesson is about the few that make us sick, how they spread, and how the body, vaccines and medicines fight back.

There are microbes in the soil, in the ocean, on your skin and in your gut. Bacteria fix nitrogen for crops, yeast raises bread, and gut bacteria help digest fiber. A small minority are pathogens, microbes that cause disease. Learning how they work, and how the immune system learns to recognize them, explains why handwashing, vaccines and careful antibiotic use matter.

1. The microbe world

A microorganism, or microbe, is any living thing too small to see clearly without a microscope. The word covers very different kinds of life. Bacteria (and the similar-looking archaea) are prokaryotes: single cells with no nucleus. Fungi such as yeasts and molds, and protists such as amoebas and algae, are eukaryotes, with a nucleus and other membrane-bound organelles, like your own cells. The difference between the two cell types is covered in The Cell. Viruses are studied alongside microbes but are not cells at all.

Sizes span a huge range. A typical virus is about 100 nanometers across, roughly ten times smaller than a typical bacterium at about 1 micrometer, which is itself at least ten times smaller than a typical plant or animal cell at 10 to 100 micrometers. Your eye can make out objects only from about 100 micrometers up (see OpenStax Microbiology 1.3).

Log scale from 10 nanometers to 1 millimeter, each step ten times bigger, with labeled drawings of a virus near 100 nanometers, a bacterium near 1 micrometer, a yeast cell of a few micrometers, an animal cell at tens of micrometers, and the shaded range visible to the naked eye from about 100 micrometers 10 nm100 nm1 µm10 µm100 µm1 mmvirusbacteriumyeastanimal cellnakedeye

Big enough to see without a microscope

The same scale in words. Each step is ten times larger than the one before.
SizeTypical example
About 100 nmA virus (range roughly 20 to 900 nm, see OpenStax Microbiology 6.1)
About 1 to 10 µmA bacterium (about 1 µm); a baker's yeast cell (typically about 4 to 6 µm, see Sherman, p. 15)
About 10 to 100 µmA plant or animal cell
About 100 µm and upVisible to the naked eye

Explore: a microbe gallery

Bacterium: Escherichia coli
Prokaryote · about 1 µm across, like a typical bacterium. A rod-shaped bacterium with no nucleus. Most strains live harmlessly in the gut; a few cause food poisoning. In the lab it can divide by binary fission about every 20 minutes when conditions are ideal.
Bacterium: Streptococcus
Prokaryote · round cells in chains. Round bacteria that stay stuck together in chains after dividing. Some species live harmlessly in the mouth and throat; Streptococcus pyogenes causes strep throat. Yogurt makers use a harmless relative to ferment milk.
Virus: a bacteriophage
Virus · not a cell. A virus that infects bacteria. Its protein head holds DNA; the tail lands on a bacterium and injects the DNA, leaving the empty coat outside. Phages were key to working out that genes are made of DNA.
Virus: influenza
Virus · about 100 nm, like a typical virus. An enveloped virus: its genes (RNA, split into several pieces) sit inside a protein coat wrapped in a membrane taken from the last cell it left. Spikes on the surface let it grab and leave cells. Those spikes change over time, which is one reason flu vaccines are updated.
Fungus: baker's yeast
Eukaryote · single-celled fungus. A one-celled fungus with a nucleus. It reproduces by budding: a small daughter cell swells out of the parent and pinches off. Its fermentation makes bread rise and turns sugar into alcohol.
Fungus: Penicillium mold
Eukaryote · many-celled fungus. Thread-like hyphae spread through food and soil, digesting it from outside. Brush-shaped stalks release spores into the air. One species produced the first penicillin; others give blue cheese its veins.
Protist: Plasmodium
Eukaryote · single-celled parasite. The cause of malaria, carried between people by Anopheles mosquitoes. Inside a person it multiplies in the liver and then in red blood cells, as drawn here, bursting them in waves that bring fever and chills.

2. Bacteria

A bacterium is a complete living cell, just a simple one. Its DNA is a single circular chromosome sitting in a region called the nucleoid, not wrapped in a nucleus. Many bacteria also carry small extra rings of DNA called plasmids, which can be passed from one bacterium to another; plasmids often carry genes for antibiotic resistance, which comes up again in section 8.

Cutaway drawing of a rod-shaped bacterium with nine numbered parts, listed in the key 123456789
  1. Capsule: a sticky outer layer some bacteria have, helping them cling to surfaces and dodge immune cells
  2. Cell wall: a rigid layer that holds the cell's shape; plant cells have walls too, but bacterial walls are made of different material
  3. Cell membrane: controls what enters and leaves
  4. Cytoplasm: the watery inside, where most chemistry happens
  5. Nucleoid: the region holding the circular chromosome
  6. Plasmid: a small extra loop of DNA
  7. Ribosomes: make proteins; they are smaller than yours, which lets some antibiotics target them
  8. Flagellum: a whip-like tail that spins to push the cell along
  9. Pili: short hair-like threads for sticking to surfaces and swapping DNA

Binary fission. Bacteria reproduce by copying their chromosome, growing, and splitting into two identical cells. In good conditions this can be startlingly fast: E. coli can double in as little as 20 minutes in the lab, while the tuberculosis bacterium takes 15 to 20 hours (see OpenStax Microbiology 9.1). Fast doubling, plus occasional mutations, means bacterial populations can evolve quickly.

Helpful and harmful. Most bacteria do not harm us. Gut bacteria help break down fiber and make some vitamins, soil bacteria recycle dead matter, and nitrogen-fixing bacteria make nitrogen usable by plants, which is part of the nitrogen cycle covered in Ecology and Ecosystems. Pathogenic bacteria cause diseases such as tuberculosis, strep throat, cholera and some food poisoning. Some damage tissue directly; many release toxins.

3. Viruses

A virus particle, or virion, is genetic material (DNA or RNA) packed inside a protein coat called a capsid. Some viruses, like influenza and the coronaviruses, also have an outer envelope of membrane taken from the cell they left. Virions vary from about 20 nanometers for small viruses up to about 900 nanometers (see OpenStax Microbiology 6.1).

Are viruses alive? Most biologists say not quite. A virus has genes and can evolve, but it has no metabolism, no ribosomes and no way to copy itself on its own. Outside a cell it is an inert particle. Only inside a host cell, using that cell's machinery, does it reproduce. That is why viruses are usually described as being on the edge of life rather than as organisms. Each kind of virus can infect only certain cells, depending on whether its surface proteins can attach to receptors on them.

Viruses that infect bacteria, called bacteriophages (phages for short), show two strategies clearly (see OpenStax Microbiology 6.2).

Lytic cycle

  1. Attach. The phage sticks to receptors on the bacterium.
  2. Inject. It pushes its DNA inside; the empty coat stays outside.
  3. Take over. The cell is made to copy the viral DNA and build viral proteins.
  4. Assemble. New phages are put together inside the cell.
  5. Burst. The cell splits open (lysis), releasing new phages to infect neighbors.

Lysogenic cycle

  1. Attach and inject, as in the lytic cycle.
  2. Join in. The viral DNA inserts itself into the bacterial chromosome, where it is called a prophage.
  3. Lie low. Each time the bacterium divides, it copies the prophage too, so every daughter cell carries it.
  4. Switch. A trigger such as stress can cut the prophage out, and it enters the lytic cycle.

Animal viruses can behave in similar ways. HIV inserts a DNA copy of its genes into the chromosomes of the white blood cells it infects, and the virus behind chickenpox can hide in nerve cells for decades before returning as shingles.

4. Fungi and protists

Fungi include single-celled yeasts and many-celled molds and mushrooms. They absorb food from their surroundings after breaking it down with enzymes, which makes them important decomposers. A few cause human disease, usually on the skin or in people whose immune systems are weakened: athlete's foot and thrush are fungal infections. Because fungi are eukaryotes like us, drugs that kill them tend to have more side effects than antibiotics do.

Protists are a catch-all group of eukaryotes that are not plants, animals or fungi. Most are harmless, and algae among them make a large share of the world's oxygen. The best-known pathogen is Plasmodium, the parasite that causes malaria. A female Anopheles mosquito injects it while feeding. It multiplies first in the liver and then inside red blood cells, which burst in waves, causing cycles of fever and chills. Here the mosquito is a vector, an animal that carries a pathogen between hosts.

5. How disease spreads

The germ theory of disease, the idea that specific microbes cause specific infectious diseases, only became widely accepted in the late 1800s. Before that, illness was blamed on bad air or imbalanced body fluids. The timeline in section 9 shows how evidence piled up in the 1800s.

Pathogens travel between hosts in a few main ways (see OpenStax Microbiology 16.3):

Epidemiologists summarize how contagious a disease is with its basic reproduction number, R0 ("R-nought"): the average number of people one infected person infects in a population where everyone is susceptible. If R0 is above 1, each case leads to more than one new case and an outbreak can grow. Below 1, it dies out. R0 is not a fixed property of a germ: it also depends on how people live and mix.

A classic way to model an outbreak, going back to Kermack and McKendrick in 1927, splits a population into three groups: Susceptible, Infected and Recovered (or removed) (see Kermack & McKendrick). People move from S to I to R. As immune people build up, each case finds fewer susceptible people to infect, and the outbreak slows. Vaccination moves people straight into the immune group before the outbreak begins.

If a fraction of people are immune, each case infects on average R0 times the fraction who are still susceptible. Spread stalls once that falls below 1, which gives a rough herd immunity threshold of 1 − 1/R0 (see Fine et al.). For R0 = 4 the arithmetic gives 1 − 1/4 = 75%. Real thresholds are higher if a vaccine does not fully protect everyone, and they change when people mix unevenly (see Fine et al.).

Explore: a toy outbreak model

This is a toy model, not a forecast for any real disease. It follows 1000 people who mix at random, starting with one infected person. Each person stays infectious for a week on average, the vaccine works perfectly and protection lasts. Pick an R0, then change how many people are vaccinated before the outbreak starts.

Turn on JavaScript to run the model. With R0 set to 4, the model gives these totals out of 1000 people: no one vaccinated, 981 infected; 50% vaccinated, 399; 70%, 96; 75%, 20; 80%, 5. The big drop comes near the 75% threshold.

Real outbreaks are messier: people mix in households and schools, not at random; vaccines do not protect everyone; chance matters a lot when cases are few.

6. The immune response

The Human Body introduced the two branches of immunity. Here is how they work together during an infection.

Barriers

Most microbes never get in. Skin is a tough, dry, slightly acidic wall. Mucus in the airways traps particles, and tiny hairs called cilia sweep it up to be swallowed. Tears and saliva contain an enzyme, lysozyme, that attacks bacterial cell walls. Stomach acid kills many swallowed microbes, and harmless bacteria on the skin and in the gut crowd out newcomers.

Innate defenses: fast and general

When something does get through, say via a cut, the innate system responds within minutes to hours, in the same way every time.

Adaptive defenses: slow to start, precise, and with memory

The adaptive system is built from lymphocytes: B cells and T cells (see OpenStax Biology 42.2). Each lymphocyte carries receptors that fit one particular antigen, a molecule (usually part of a protein) that the immune system can recognize. Across the body there are millions of different receptor shapes, made by shuffling gene segments, so whatever germ arrives, a few cells will already fit it.

  1. Antigen presentation. A phagocyte, often a dendritic cell, engulfs the invader, chops it up and displays fragments on its surface. It travels to a lymph node to show them to T cells.
  2. Helper T cells whose receptors match become activated. They release signals that switch on the right B cells and cytotoxic T cells.
  3. Clonal selection. Only the lymphocytes that match the antigen are activated, and they divide again and again, making a large clone of identical cells. This takes days, which is why you feel ill for a while during a first infection.
  4. B cells turn into plasma cells that pour out antibodies. Antibodies bind the antigen, blocking viruses from entering cells, clumping bacteria and tagging them for phagocytes (see OpenStax Biology 42.3).
  5. Cytotoxic T cells hunt down body cells displaying the matching fragment, a sign that they are infected, and make them self-destruct, stopping the virus being copied.
  6. Memory. When the infection clears, most of the clone dies off, but long-lived memory B and T cells remain.

First and second exposure

The memory cells are why you rarely catch measles or chickenpox twice. Meeting the same antigen again triggers a secondary response that is faster and stronger than the first, often stopping the infection before you notice symptoms (see OpenStax Microbiology 18.1).

Schematic, not to scale: after a first exposure antibody levels rise slowly to a small peak and fall; after a second exposure to the same antigen after a shorter lag they rise faster and much higher 1st exposure2nd exposuretime →antibody level

Schematic, not to scale. After the first exposure, antibody levels rise after a delay to a modest peak, then fall. After a second exposure to the same antigen, they rise sooner, climb much higher and stay up longer.

7. Vaccines

A vaccine gives the adaptive immune system a preview of a pathogen's antigens without the danger of the real disease. Antigen-presenting cells, helper T cells and B cells go through the same steps as in a real infection, leaving memory cells behind, so a later real infection meets a secondary response (see OpenStax Microbiology 18.5). Some vaccines need booster doses to build or refresh that memory.

TypeWhat is in itExamples
Live attenuatedA weakened form of the pathogen that can still multiply a little but does not cause the disease in healthy people. Often gives strong, long-lasting protection, but is not suitable for people with very weak immune systems.Measles, mumps and rubella (MMR); chickenpox
InactivatedWhole pathogens killed with heat or chemicals, so they cannot multiply. Safer, but usually needs boosters.Injected polio vaccine; most flu shots
SubunitOnly selected pieces of the pathogen, such as a surface protein, or an inactivated toxin (a toxoid).Hepatitis B; HPV; tetanus
mRNAInstructions, wrapped in a tiny fat bubble, for your own cells to make one antigen for a short time. The mRNA breaks down within days and does not enter the nucleus or change your DNA.COVID-19 vaccines, such as Pfizer-BioNTech's, tested in a large trial (see Polack et al.)

Vaccines protect the person who gets one, and by cutting the number of susceptible people, they also slow spread to people who cannot be vaccinated, such as newborns. Smallpox was eradicated this way, the only human disease so far (see WHO).

8. Antibiotics and resistance

Antibiotics are drugs that kill bacteria or stop them multiplying. They work by hitting structures bacteria have and our cells do not, or have in a different form: penicillin blocks the building of bacterial cell walls, while others jam bacterial ribosomes. Viruses have no cell wall and no ribosomes of their own, so antibiotics do nothing against viruses such as colds and flu. Viral infections are treated with rest, sometimes antiviral drugs, and prevented with vaccines.

Resistance is natural selection. In a large population of bacteria, a few may carry a mutation, or a gene picked up on a plasmid, that helps them survive a drug. When the antibiotic kills the rest, those survivors have less competition and multiply, and resistance becomes common. The drug does not create resistance; it selects for it. This is the same process described in Evolution, happening fast enough to watch. Overuse of antibiotics in people and farm animals speeds it up.

What about finishing the course? Patients have long been told to finish every antibiotic course to avoid resistance. Some doctors now argue that this advice has little evidence behind it for many infections, since longer use also exposes the bacteria in your gut and on your skin to the drug, selecting for resistance there; for many infections shorter courses work as well (see Llewelyn et al.). Others point out that for some infections, such as tuberculosis, stopping early is dangerous. The safe rule is to take antibiotics exactly as prescribed and talk to the prescriber before stopping. The model below shows the selection idea, not a dosing rule.

Explore: a toy resistance model

This is a toy model with made-up numbers. An infection starts with a million ordinary bacteria and a thousand tougher ones (0.1%). Each day on the drug kills 75% of the ordinary ones but only 40% of the tough ones. Off the drug, both double every day up to a million. If fewer than 100 are left, the model assumes the immune system finishes the job. Choose the day the drug is stopped.

Turn on JavaScript to run the model. Stopping after 3 days leaves survivors that regrow with about 1.4% tough bacteria, up from 0.1%; stopping after 5 days, about 7%. After 7 days of the drug, this toy infection is cleared, so in the model days 8 to 10 make no difference.

Notice both lessons: stopping while many bacteria survive leaves a regrown infection that is richer in tougher bacteria, yet extra days beyond what is needed add nothing here. In real patients, the right length depends on the infection, which is why it is the prescriber's call.

9. How do we know?

Germ theory was not obvious. It took two centuries of microscopes, careful experiments and arguments to move from "little animals" in a drop of water to vaccines designed on a computer.

  1. 1676 Antonie van Leeuwenhoek, a Dutch cloth merchant grinding his own lenses, writes to the Royal Society describing "little animals" in drops of water. They were bacteria and protists, seen for the first time. (Lane)
  2. 1796 Edward Jenner protects a boy against smallpox by first infecting him with cowpox, the start of vaccination. (Riedel)
  3. 1847 Ignaz Semmelweis has doctors in his Vienna maternity ward wash their hands in chlorinated lime after dissections, and deaths from childbed fever fall sharply. Many colleagues rejected the idea. (Best & Neuhauser)
  4. 1854 During a cholera outbreak in London, John Snow maps the deaths and traces them to a water pump on Broad Street, evidence that the disease spreads through water, not bad air. (Brody et al.)
  5. 1859–62 Louis Pasteur boils broth in swan-neck flasks. Air can get in, but dust and microbes settle in the bend, and the broth stays clear. Life in it comes from microbes already present, not spontaneous generation. (Roll-Hansen)
  6. 1867 Joseph Lister, inspired by Pasteur, reports treating wounds with carbolic acid to kill germs, and infections after surgery drop. (Lister)
  7. 1876, 1882 Robert Koch shows that a specific bacterium causes anthrax, then identifies the bacterium behind tuberculosis. His step-by-step tests for linking one microbe to one disease became known as Koch's postulates. (Blevins & Bronze)
  8. 1892, 1898 Dmitri Ivanovsky finds that the agent of tobacco mosaic disease passes through filters that stop bacteria. Martinus Beijerinck repeats the work and argues it is a new kind of infectious agent, which he calls a virus. On which date counts as the discovery, see Lecoq. (Beijerinck)
  9. 1928, 1940 Alexander Fleming notices that a Penicillium mold kills bacteria around it. Twelve years later, Howard Florey, Ernst Chain and their team show that purified penicillin cures infections in mice. (Chain et al.)
  10. 1957 Frank Macfarlane Burnet proposes clonal selection: each lymphocyte carries one kind of receptor, and the ones that meet their antigen multiply. (Burnet)
  11. 1980 The World Health Organization declares smallpox eradicated, the first human disease wiped out by vaccination. (WHO)
  12. 2020 The first mRNA vaccine, Pfizer-BioNTech's against COVID-19, is authorized for use: by the UK regulator on 2 December, then for emergency use by the US FDA on 11 December (see FDA). (MHRA)

Quiz: Immunity check

Talk about it

  1. Semmelweis had good evidence that handwashing saved lives, but many doctors rejected it. Why might experts resist evidence that they themselves were causing harm?
  2. In the outbreak model, try R0 = 8. Why does a more contagious disease need a higher share of people vaccinated to stop it spreading?
  3. Viruses can evolve but cannot reproduce on their own. Would you call them alive? What definition of life are you using?
  4. Advice on antibiotic courses has shifted as evidence has changed. How should doctors explain a change in advice without losing people's trust?
  5. Your body carries a large population of harmless bacteria. What might be lost when an antibiotic kills them along with the pathogen?

Sources

  1. Parker, N. et al. (2016). 1.3 Types of Microorganisms. Microbiology. OpenStax. States that a typical virus is about 100 nm, a typical bacterium about 1 µm and a typical plant or animal cell about 10–100 µm, and that objects must be about 100 µm to be seen without a microscope. openstax.org/books/microbiology/pages/1-3-types-of-microorganisms
  2. Parker, N. et al. (2016). 6.1 Viruses. Microbiology. OpenStax. States that virions range from about 20 nm to 900 nm. openstax.org/books/microbiology/pages/6-1-viruses
  3. Parker, N. et al. (2016). 6.2 The Viral Life Cycle. Microbiology. OpenStax. openstax.org/books/microbiology/pages/6-2-the-viral-life-cycle
  4. Parker, N. et al. (2016). 9.1 How Microbes Grow. Microbiology. OpenStax. States that E. coli can double in as little as 20 minutes under optimal laboratory conditions and that M. tuberculosis has a generation time of 15 to 20 hours. openstax.org/books/microbiology/pages/9-1-how-microbes-grow
  5. Parker, N. et al. (2016). 16.3 Modes of Disease Transmission. Microbiology. OpenStax. Describes direct droplet transmission over distances of one meter or less. openstax.org/books/microbiology/pages/16-3-modes-of-disease-transmission
  6. Parker, N. et al. (2016). 18.1 Overview of Specific Adaptive Immunity. Microbiology. OpenStax. openstax.org/books/microbiology/pages/18-1-overview-of-specific-adaptive-immunity
  7. Parker, N. et al. (2016). 18.5 Vaccines. Microbiology. OpenStax. openstax.org/books/microbiology/pages/18-5-vaccines
  8. Clark, M. A., Douglas, M. & Choi, J. (2018). 42.2 Adaptive Immune Response. Biology 2e. OpenStax. openstax.org/books/biology-2e/pages/42-2-adaptive-immune-response
  9. Clark, M. A., Douglas, M. & Choi, J. (2018). 42.3 Antibodies. Biology 2e. OpenStax. openstax.org/books/biology-2e/pages/42-3-antibodies
  10. Kermack, W. O. & McKendrick, A. G. (1927). A contribution to the mathematical theory of epidemics. Proceedings of the Royal Society A 115: 700–721. doi:10.1098/rspa.1927.0118
  11. Fine, P., Eames, K. & Heymann, D. L. (2011). "Herd immunity": a rough guide. Clinical Infectious Diseases 52: 911–916. Gives the threshold 1 − 1/R0. doi:10.1093/cid/cir007
  12. Llewelyn, M. J. et al. (2017). The antibiotic course has had its day. BMJ 358: j3418. doi:10.1136/bmj.j3418
  13. Lane, N. (2015). The unseen world: reflections on Leeuwenhoek (1677) "Concerning little animals". Philosophical Transactions of the Royal Society B 370: 20140344. doi:10.1098/rstb.2014.0344
  14. Riedel, S. (2005). Edward Jenner and the history of smallpox and vaccination. Baylor University Medical Center Proceedings 18: 21–25. doi:10.1080/08998280.2005.11928028
  15. Best, M. & Neuhauser, D. (2004). Ignaz Semmelweis and the birth of infection control. Quality and Safety in Health Care 13: 233–234. doi:10.1136/qshc.2004.010918
  16. Brody, H. et al. (2000). Map-making and myth-making in Broad Street: the London cholera epidemic, 1854. The Lancet 356: 64–68. doi:10.1016/S0140-6736(00)02442-9
  17. Roll-Hansen, N. (1979). Experimental method and spontaneous generation: the controversy between Pasteur and Pouchet, 1859–64. Journal of the History of Medicine and Allied Sciences 34: 273–292. doi:10.1093/jhmas/XXXIV.3.273 See also OpenStax Microbiology 3.1.
  18. Lister, J. (1867). On a new method of treating compound fracture, abscess, etc. The Lancet 90: 353–356. doi:10.1016/S0140-6736(02)51827-4
  19. Blevins, S. M. & Bronze, M. S. (2010). Robert Koch and the "golden age" of bacteriology. International Journal of Infectious Diseases 14: e744–e751. doi:10.1016/j.ijid.2009.12.003
  20. Sherman, F. (2002). Getting started with yeast. Methods in Enzymology 350: 3–41, p. 15: haploid cells are typically 4 µm spheroids and diploid cells 5 × 6 µm ellipsoids. doi:10.1016/S0076-6879(02)50954-X
  21. Beijerinck, M. W. (1898). Ueber ein Contagium vivum fluidum als Ursache der Fleckenkrankheit der Tabaksblätter. Verhandelingen der Koninklijke Akademie van Wetenschappen te Amsterdam, Tweede Sectie, Deel 6, No. 5. dwc.knaw.nl
  22. Lecoq, H. (2001). Découverte du premier virus, le virus de la mosaïque du tabac : 1892 ou 1898 ? Comptes Rendus de l'Académie des Sciences III 324: 929–933. doi:10.1016/S0764-4469(01)01368-3
  23. Fleming, A. (1929). On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzæ. British Journal of Experimental Pathology 10: 226–236. pmc.ncbi.nlm.nih.gov/articles/PMC2048009
  24. Chain, E., Florey, H. W. et al. (1940). Penicillin as a chemotherapeutic agent. The Lancet 236: 226–228. doi:10.1016/S0140-6736(01)08728-1 For Fleming's 1928 observation, see also OpenStax Microbiology 14.1 and Fleming (1929).
  25. Burnet, F. M. (1957). A modification of Jerne's theory of antibody production using the concept of clonal selection. Australian Journal of Science 20: 67–69. Reprinted (1976) in CA: A Cancer Journal for Clinicians 26: 119–121. doi:10.3322/canjclin.26.2.119
  26. World Health Organization. Smallpox. States that WHO declared smallpox eradicated in 1980. who.int/health-topics/smallpox
  27. US Food and Drug Administration (2021). FDA approves first COVID-19 vaccine. States that the Pfizer-BioNTech vaccine had been available under emergency use authorization since 11 December 2020. fda.gov
  28. Medicines and Healthcare products Regulatory Agency (2020). UK medicines regulator gives approval for first UK COVID-19 vaccine. Published 2 December 2020; states the Pfizer/BioNTech vaccine was approved that day. gov.uk
  29. Polack, F. P. et al. (2020). Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. New England Journal of Medicine 383: 2603–2615. doi:10.1056/NEJMoa2034577